The Pericapsular Nerve Block in Total Hip Arthroplasty
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLifeBridge Health
About this trial
In order to continue progressing towards outpatient total hip arthroplasty (THA), methods to adequately manage postoperative pain is of paramount importance. The purpose of this study is to quantify the effectiveness of the pericapsular nerve block in total hip arthroplasty in comparison to the fascia iliaca nerve block.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Planned primary total hip arthroplasty with anterior (Smith-Peterson) approach
ASA score of 1 to 3
Disqualifiers
Current or previous diagnosis of "chronic pain"
Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid.)
Diagnosis of ankylosing spondylitis
Allergy to any potential medications utilized in any of the two groups
Trial design
Treatments tested in this trial
- Pericapsular Nerve Block
- Fascia Iliaca Nerve Block
Treatment groups
78 Participants
are divided into 2 treatment groupsSponsors and collaborators
LifeBridge Health
Lead sponsor
Rubin Institute for Advanced Orthopedics
Collaborator
Source ClinicalTrials.gov